Hokko Chemical Industry (4992) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
14 Oct, 2026Executive summary
H1 FY2026 revenue rose 7.1% YoY to ¥32.849bn; operating profit increased 14.4% to ¥4.184bn and net income attributable to owners rose 20.7% to ¥3.380bn.
Agriculture drove sales and profit growth; Fine Chemicals weakened and Textile Materials was broadly stable.
The three-year management plan continues to focus on earnings and production-base improvements, growth investment, and reforms in profitability, manufacturing and work style.
Financial highlights
Revenue was ¥32.849bn, up ¥2.183bn YoY; operating profit was ¥4.184bn, up ¥527m; ordinary profit was ¥4.657bn, up ¥698m.
Net income attributable to owners was ¥3.380bn, up ¥580m YoY, including a ¥237m gain on sale of investment securities; H1 EPS was ¥131.10, versus ¥106.18 a year earlier.
Ordinary profit increased 17.6% YoY, with ¥27m in foreign-exchange gains versus ¥111m in FX losses in the prior-year period.
Outlook and guidance
FY2026 forecasts remain unchanged: revenue ¥52.0bn, operating profit ¥5.2bn, ordinary profit ¥6.1bn and net income ¥4.46bn.
H1 achieved 63.2% of forecast revenue, 80.5% of operating profit, 76.3% of ordinary profit and 75.8% of net income; profit-stage progress rates exceeded prior-year levels.
A new long-term plan for FY2027–FY2035 is in development, centered on a ¥100bn revenue vision; publication is planned by November 2026.
Latest events from Hokko Chemical Industry
- Pesticide growth lifted revenue, but fine-chemical weakness cut Q1 profits.4992
Q1 2024 - H1 revenue and net income rose, while operating income fell amid cost pressure.4992
Q2 2024 - Revenue rose, operating profit fell on costs and competition; a share buyback was approved.4992
Q3 2024 - FY2024 earnings grew; FY2025 guidance projects higher sales and operating profit.4992
Q4 2024 - Pesticide-led growth lifted Q1 revenue; Fine Chemicals profit fell, and 5% of shares were canceled.4992
Q1 2025 - Pesticide-led growth lifted profit; earnings guidance held as the dividend forecast rose.4992
Q3 2025 - Agrochemical-led Q1 growth accompanied higher FY2029 targets.4992
Q1 2026 - Pesticide-led growth lifted H1 results as fine chemicals weakened; a buyback was approved.4992
Q2 2025 - Record ordinary profit and strong agrochemical sales; FY2026 dividend projected higher.4992
Q4 2025